Stem Cell Banking Market - Global Leaders & Different Growth Adopted by Them

Key Market Players:

As of 2017, the global stem cell banking market was dominated by Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), and ViaCord (US). Other key players in the stem cell banking market included Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico), among others.

Different Growth Strategies Adopted by Them:

Analysis of the market developments between 2015 and 2018 reveals that several growth strategies such as service launches & upgrades; agreements, partnerships, & collaborations; and mergers & acquisitions were adopted by the market players to strengthen and competitive position in the global stem cell banking market. Among these business strategies, agreements, partnerships, & collaborations were the most widely adopted growth strategies by majority of market players worldwide.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220680183

Cord Blood Registry (CBR) Systems held the leading position in the global stem cell banking market in 2017. The company has a widespread presence and large customer base in the US. The company primarily focuses on advancing its umbilical cord preservation services through the adoption of inorganic growth strategies such as collaborations and partnerships.

In regard to this, in 2017, the company collaborated with the New York Stem Cell Foundation (US) to develop induced pluripotent stem cells from umbilical cords. In addition to this, in 2015, the company entered into a strategic collaboration with Global Cord Blood Corporation (China) to integrated their methodologies for the collection, processing, and storage of umbilical cords and improve the overall stem cell banking service standards in the US and China.

Cordlife secured the second position in the global stem cell banking market in 2017. The company is a leading player in the Asian stem cell banking market with its robust presence across eight countries and high-quality services. To sustain its leading position in the Asian region, the company mainly focuses on increasing its customer base through agreements. For instance, in 2017, the company entered into an agreement with IPS Trading and Service Joint Stock Company (Vietnam) to offer umbilical cord banking services and non-invasive metabolic newborn screening in Vietnam. Similarly, in 2016, the company collaborated with Bio Secure Company Limited (Myanmar) to offer umbilical cord banking services in Myanmar.

Cryo-Cell International held the third position in the stem cell banking market in 2017. The company is one of the key private stem cell banking providers in the global market. The company’s key strengths are its significant geographic presence and unique state-of-the-art technology for banking operations. The company mainly focuses on acquiring patents for the collection, testing, processing, and preservation of umbilical cord blood and tissues. For instance, in 2015, the company acquired assets of Prepacyte-CB (a cord blood business of CytoMedical Design Group LLC) to advance its existing technology for processing of cord blood and tissues.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=220680183

North America is expected to dominate the stem cell banking market in 2019

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share in 2019. The expanding network of stem cell banking services across the region, ongoing approval of stem cell lines for disease treatment (especially for hematopoietic & autoimmune disorders), recent technological advancements in the field of stem cell collection and preservation techniques, and rising public-private investments for stem cell researches are driving the growth of the stem cell banking market in North America.

Healthcare IT Industry - Major Revenue Surge is Expected Due to These Factors

Expected Growth in Revenue Generation:

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period.

Major Growth Boosting Factors

The demand for healthcare IT solutions and services is driven by government mandates & support for healthcare IT solutions, rising use of big data in healthcare, high returns on investment for healthcare IT solutions, and the need to curtail escalating healthcare costs.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare IT market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The industry’s market size, in terms of value, has been determined through primary and secondary research.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Data Triangulation:

After arriving at the overall market size—using market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Industry Segmentation:

“The healthcare provider solutions segment is estimated to grow at the highest CAGR during the forecast period”

The healthcare provider solutions segment is estimated to witness the highest growth in the Healthcare IT market, by product and services, during the forecast period. Growth in this segment is attributed to the increasing demand for improved patient safety and patient care, stringent regulations regarding healthcare provider solutions, and the need for integrated healthcare systems.

“The healthcare payer fraud detection analytics market is estimated to witness high growth from 2019 to 2024”

Based on healthcare payers solutions, the market is segmented into claims management, customer relationship management, payer fraud analytics solutions, provider network management, pharmacy audit & analysis, member eligibility management, population health management solutions, and payment management solutions. The fraud analytics solutions is estimated to witness high growth from 2019 to 2024.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=252

Geographical Growth Scenario:

“North America dominated the Healthcare IT market in 2018”

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018.

The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Global Industry Players:

Although, the global healthcare IT market is largely fragmented in nature with presence of number of small and mid-sized vendors operating at local and regional levels, Cerner Corporation (US), Optum (US), Cognizant (US), Philips Healthcare (Netherlands) and Epic Systems (US) are some of the leaders in the healthcare IT solutions market.

Read the Detailed Report@

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Animal Parasiticides Market to Experience Steady Rate to Gain Exponential Revenue Growth

Research Methodologies Followed for This Research:

Primary Research:

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include CEOs, consultants, subject-matter experts, directors, general managers, developers, and other key opinion leaders of companies that offer animal parasiticides.

Primary research was conducted to identify segmentation types, industry trends; animal types; key players; key market dynamics such as drivers, opportunities, challenges; and key player strategies.

Secondary Research:

Various secondary sources such as the World Health Organization (WHO), International Federation for Animal Health (IFAH), Animal Health Institute (AHI), and American Pet Products Association (APPA), alongside the annual reports, press releases, and filings of market players, have been used to identify and collect information useful for this market study.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258895412

Overview of This Study:

The study involved four major activities for estimating the size of the animal parasiticides market. Exhaustive secondary research was done to collect information on the market, including its peer markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Target Audience:

# Veterinary hospitals and clinics

# Veterinary research institutes

# Animal health companies

# Animal farms

# Government associations

# Market research and consulting firms

# Venture capitalists and investors

The animal farms segment is expected to witness the highest growth rate in the animal parasiticides market, by end user, during the forecast period

Based on end user, the animal farms segment is expected to register the highest CAGR during the forecast period. The increasing incidence of parasitic diseases and rising demand for animal-derived food products are the major factors supporting the growth of this segment.

Recent Developments:

# In February 2020, Zoetis launched Simparica Trio, a parasiticide for dogs with, or at risk from, mixed external and internal parasitic infestations.

# In February 2020, Elanco signed an agreement with Merck Animal Health to divest its worldwide rights for Vecoxan, used for the prevention and treatment of coccidiosis in calves and lambs.

# In February 2020, Vetoquinol acquired rights to Profendor and Drontal (parasiticides for companion animals offered by Elanco) for the European Economic Area and the UK.

# In August 2019, Boehringer Ingelheim opened a Health Management Center in China.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=258895412

North America dominated the animal parasiticides market in 2019

North America accounted for the largest share of the animal parasiticides market in 2019, followed by Europe and the Asia Pacific. High pet spending,increased awareness about animal health, and the growing companion animal population are the major factors responsible for the large share of North America in the animal parasiticides market.

Global Leaders:

The global animal parasiticides market is fragmented, with many regional and global players vying for larger market shares. Bayer AG (Germany), Boehringer Ingelheim (Germany), Elanco (US), Zoetis (US), Merck (US), and PetIQ (US) are the major players in this market.

Read the Detailed Article@ 
https://www.marketsandmarkets.com/Market-Reports/animal-parasiticide-market-258895412.html

Major Revenue Surge is Expected in the Global Human Organoids Market

Overview of This Research Study:

The study involved four major activities to estimate the current size of the human organoids market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth:

The global human organoids market size is projected to reach USD 1,901 million by 2025 from USD 850 million in 2020, at a CAGR of 17.5% during the forecast period.

Growth Boosting Factors:

The global human organoids market offers significant growth potential for prominent as well as emerging product manufacturers. Technological advancements, rising incidence of transplants, and increased funding and public-private investments are key factors driving the growth of the human organoids market.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468

The human organoids market includes major Tier I and II suppliers like BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK), and MIMETAS (Netherlands). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for human organoids from key end-users has declined a bit amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have short-term decline in the growth for the human organoids market in 2020, but will experience normal growth as the market gradually steadies by the end of 2020.

Demand for liver transplants result in the segment occupying the high share of the human orgnaoids market

Liver segment owes a good market share in Human Orgnaoids market. The large share of this segment is attributed to factors such as the advancements in technology among researchers and academia (coupled with growing industry-academia collaborations for organoids research, rising numbers of liver transplants and the investments by the both private and public players in the market.

Kidney estimated to be the growing market

The kidney human orgnaoids market is expected to witness sustained demand during the forecast period, owing to the high prevalence of infectious diseases across major markets (resulting in a growing number of transplant procedures), and an increasing number of life science researches in the field of specific requirements and treatment, especially across emerging countries.

Asia Pacific likely to emerge as the fastest growing clinical microbiology market, globally

Geographically, the emerging Asian countries, such as China, India, South Korea, Taiwan, and Singapore, are offering high-growth opportunities for market players. The Asia Pacific clinical microbiology market is projected to grow at the highest CAGR of 18.8% from 2020 to 2025. Government efforts to increase awareness related to human organoids; supportive regulations for the development and commercialization of advanced human orgnaoids products; rising healthcare expenditure; the increasing number of hospitals in India and China; expanding research base across India, China, and Japan; and the increasing incidence of transpalnts are driving the growth of the APAC clinical microbiology market.

Global Leaders:

Prominent players in this market BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK), and MIMETAS (Netherlands).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468

Osteoarthritis Therapeutics Market - Collaborations for Product Development Was one of the Growth Strategies Adopted by Key Players

What is Osteoarthritis?

Osteoarthritis is the most common form of arthritis and generally affects the bones that bear the body’s weight. While this medical condition cannot be reversed, medications and injections have been found to be effective in the reducing the pain caused due to osteoarthritis. Drugs such as NSAIDs, analgesics, corticosteroids, and viscosupplement agents are being used widely to manage osteoarthritis.

Global Leaders:

The osteoarthritis therapeutics market is a highly fragmented market and has presence of various players. The major players operating in this market are Sanofi (France), Horizon Therapeutics PLC (Ireland), Johnson & Johnson (US), GlaxoSmithKline PLC (UK), Bayer AG (Germany), Abbott (US), Pfizer, Inc. (US), Eli Lilly (US), Anika Therapeutics, Inc. (US), Novartis AG (Switzerland), Ferring Pharmaceuticals (Switzerland), Bioventus (US), Zimmer Biomet Holdings, Inc. (US), Fidia Farmaceutici s.p.a. (Italy), Flexion Therapeutics, Inc. (US), Pharmed Limited (India), Virchow Biotech (India), Kitov Pharmaceuticals Ltd. (Israel), Assertio Therapeutics, Inc. (US), Atnahs (UK), Almatica Pharma LLC (US), OrthogenRx (US), LABRHA (France), Hanmi Pharm. Co., Ltd. (Korea), and Laboratorio Reig Jofre (Spain).

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209565994

Expected Revenue Growth:

The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025.

Major Growth Boosters:

The growth of this market is driven by significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number of sports injuries.

Sanofi (France)

Sanofi held the leading position in the global viscosupplementation agents market in 2019. The company offers Synvisc and Synvisc One for the treatment of pain associated with osteoarthritis. These drugs are marketed in more than 60 countries. The company invests significantly in R&D activities. In 2019, it invested USD 6.74 billion in R&D, which consisted of 16.7% of the company revenue. Sanofi showcases its products and participates in global events to increase its market visibility. The company has established a significant footprint in North America, Europe, Africa, and the Middle East. Its global footprint helps it in generating revenue from different regions.

Zimmer Biomet Holdings, Inc. (US)

Zimmer Biomet held second place in the global viscosupplementation agents market in 2019. The company offers viscosupplement-based injections for the treatment of osteoarthritis. Zimmer Biomet Holdings operates in more than 25 countries and markets its products in more than 100 countries across the Americas, Europe, and the Asia Pacific. Some of its key subsidiaries include Zimmer Spine, Inc. (US), Biomet, Inc. (US), Zimmer GmbH (Switzerland), and Zimmer Germany GmbH.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=209565994

Geographical Growth Scenario:

“Europe commanded the largest share of the osteoarthritis therapeutics market in 2020.”

On the basis of region, the osteoarthritis therapeutics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, Europe commanded the largest share of the osteoarthritis therapeutics market. The large share of this market segment can be attributed to the rising incidence of osteoarthritis, rising geriatric population, and increasing obesity rates in several European countries, coupled with the rising number of injuries due to sports and road accidents.

Key developments in the Industry:

# In 2020, GlaxoSmithKline Plc (UK) launched Voltaren in the US.

# In 2020, Horizon Therapeutics Plc (Ireland) expanded its presence in the US.

# In 2019, Kitov Pharma Ltd. (Israel) entered into an agreement with Coeptis Pharmaceuticals which has helped in the efficient distribution and commercialization of Consensi.

# In 2018, Atnahs established a sales office in Dubai, UAE.

# In 2017, Flexion Therapeutics, Inc. (US) received FDA Approval for ZILRETTA 

Global Drug Discovery Services Market - Get to Know More About the Major Industry Growth Boosters

Overview of This Study:

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global drug discovery services market.

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the drug discovery services market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Major Growth Driver: Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry

R&D activity has grown significantly in the pharmaceutical and biopharmaceutical industry. In 2017, the pharmaceutical industry alone spent USD 149.8 billion on R&D (Source: International Federation of Pharmaceutical Manufacturers & Associations). Also, pharmaceutical companies spend, on average, 17% of their revenue on R&D.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129

Pharmaceutical, biopharmaceutical, and medical device companies invest heavily in the development of novel drugs and devices, with most of the expenditure concentrated on phase III and the preclinical stages of drug development. Growth in R&D expenditure, fueled by the need for numerous preclinical and clinical services during the drug discovery and development process, is one of the major factors propelling the drug discovery services market, globally.

According to the Pharmaceutical Research and Manufacturers of America (PhRMA) Annual Membership Survey (2018), the R&D expenditure of PhRMA members increased to USD 71.4 billion in 2017 from USD 59.6 billion in 2015. Further increases in R&D spending in the coming years will provide a significant boost to drug discovery and development activities, which will ensure the growth of the drug discovery services market in the forecast period.

Expected Revenue Growth:

The global Drug Discovery Process Market size is projected to reach USD 21.4 billion by 2025 from USD 11.1 billion in 2020, at a CAGR of 14.0% during the forecast period.

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by process, type, drug type, therapeutic area, company type, and region).

Recent Developments:

# In 2020, Covance entered into a partnership with Medable to expedite the adoption of decentralized trial technology.

# In 2020, Eurofins entered into partnership with PharmaResources (China). This partnership enabled both companies to build a joint drug discovery platform to accelerate small molecule drug development.

# In 2020, LabCorp launched its extensive preclinical, clinical, and post-approval cell and gene therapy development solutions through Covance, its drug development business.

# In 2020, WuXi AppTec Research Service Division and BioSolveIT launched GalaXi, a new chemical space of tangible molecules.

# In 2020, Charles River acquired HemaCare to strengthen its Research Models Services segment through Hemacare’s broad range of human primary cell and cell processing services that support the discovery and development of cell therapies.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=138732129

Geographical Growth Scenario:

North America accounted for largest share of the drug discovery services market in 2019.

Based on the region, the global drug discovery services market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the drug discovery services market. The large share of this market segment can be attributed majorly to the presence of well-established CROs, rising R&D expenditure by pharmaceutical & biopharmaceutical companies, and the availability of latest techniques, instruments, and facilities for drug discovery research.

Global Leaders:

The major players operating in Drug Discovery Process Market Laboratory Corporation of America Holdings (US), Albany Molecular Research, Inc. (US), Charles River Laboratories International, Inc. (US), Evotec A.G. (Germany), Eurofins Scientific (Luxembourg), WuXi AppTec (China), GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US),  Pharmaceutical Product Development, LLC (US), Syngene International Ltd. (India), and Selvita S.A. (Poland)  among others.

Global Healthcare IT Market is Expected to Undergo Major Technological Transformations in Near Future

Research Methodologies Used in This Study:

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; trade directories; and databases such as D&B Hoovers and Bloomberg Business week were referred to identify and collect information for this study.

Primary Research:

The healthcare IT market comprises several stakeholders such as hospitals (small, mid-size, and large hospitals), ambulatory centers, diagnostic centers, TPAs, and stakeholders in corporate & government bodies. Primary sources from the supply side, including CEOs, vice presidents, marketing and sales directors, business development managers, technology and innovation directors of healthcare IT developing companies, suppliers, and distributors, have been considered. Demand-side primary sources include industry experts such as directors of hospitals and clinics, hospital & clinic managers, physicians, research scientists, and related key opinion leaders.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Recent Developments in the Global Healthcare IT Industry:

# In 2019, Philips launched Cares Aging & Care giving service.

# In 2018, Change Healthcare  launched Dx Gap Advisor

# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.

# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs

# In 2018, Optum collaborated with Humana (US), MultiPlan (US)  and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare

Expected Revenue Growth During Forecast Period:

The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period. The demand for healthcare IT solutions and services is driven by government mandates & support for healthcare IT solutions, rising use of big data in healthcare, high returns on investment for healthcare IT solutions, and the need to curtail escalating healthcare costs.

Key Questions Addressed in the Report

# Who are the top 10 players operating in the healthcare IT market?

# What are the driving factors, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the healthcare IT market?

# What are the growth trends in the market at the segmental and overall market levels?

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=252

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare IT market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The industry’s market size, in terms of value, has been determined through primary and secondary research.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global Leaders:

Although, the global healthcare IT market is largely fragmented in nature with presence of number of small and mid-sized vendors operating at local and regional levels, Cerner Corporation (US), Optum (US), Cognizant (US), Philips Healthcare (Netherlands) and Epic Systems (US) are some of the leaders in the healthcare IT solutions market.

Geographical Growth Scenario:

“North America dominated the Healthcare IT market in 2018”

The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.

Read the Detailed Study@ 

https://www.marketsandmarkets.com/Market-Reports/healthcare-it-252.html

Brightspark – Helps in Managing All HR Related Activities in One Place

Summary:

Brightspark Human Resource Software is a new development company that manages all the human resources work over one platform. It is a collaborative HR tool that came through extensive experience with business processes. It can be accessed from any browser. Financially backed by Exigy, the Brightspark Human Resource Software boasts over 17 years of software implementations, hence bridging the gap between the technology and business.

Brightspark USP:

Brightspark Human Resource Software primary USP lies in its broad applicability and easy-to-use. It helps the HR executive and management in giving efficient methods of ensuring that employees feel engaged with the organization. It develops a team spirit amongst the employees and hence helps in developing a healthy environment in the office.

Read More Related to, Best HR Software of 2020@

https://www.360quadrants.com/press-release/best-hr-software-of-2020-latest-quadrant-ranking-released-by-360quadrants

Brightspark Pricing:

Brightspark pricing offers three corporate plans: Starter, Standard, and Premium. The Starter plan costs $2.25 per user per month, while the Standard plan costs $4.50 per user per month. The best Brightspark pricing model is the Standard, which offers many outstanding features. The Premium model has not arrived yet.

Brightspark Demo:

The vendor offers a trial version that is free for a period of 30 days. After 30 days, the user has to choose a pricing model to continue using the features.

Features:

Ease of online activation - It facilitates the onboarding process for new employees by utilizing pre-made onboarding templates for creating new profiles. The ease of use makes it easier to learn even for new applicants.

Notices wizard - It puts new notices about the official curriculum in one place. It views, modifies, and assigns the organization’s legal notices in a single, centralized location to ensure that the business is on track for both optional and mandatory notices.

Manages payroll of employees - It keeps track of the employee’s salary, allowances, gross pay, net pay, rewards, etc. It makes the payment to the employees easier.

Attendance and leave tracking - The attendance can be marked easily through the software. It keeps track of the absence and leaves taken by the employee.

Best HR Software in 2020 and the latest associated trends@

https://blog.360quadrants.com/2020/human-resource-software/

Why to use Human Resource software?

HR software helps Human Resource professionals in automating multiple critical tasks, such as preserving employee records, time monitoring, and benefits, which enables HR personnel to concentrate on recruiting efforts, workforce performance and engagement, corporate wellness, organizational culture, and so on. The human management software can be bought and executed as on-premise or cloud-based software.

Human Resource software streamlines and enhances human resources management in ever-growing ways. By choosing the latest Human Resource software that aligns well with the business operations, any organization can best handles its talent, and keep its employees happy and improve productivity.

One critical area where hr software is used is in the screening, monitoring, and reporting on application processes related to filling positions. With the increasing internet integration, job posts, monitoring open positions, and the ability to store resumes digitally, human resource managers can satisfy recruitment, screening, and perform all operations from a central computer terminal. The capacity to performing searches and monitor jobs and applications significantly accelerate processes that would otherwise be very time-intense to implement.

Read Detailed Article@

https://www.360quadrants.com/software/human-resource-software

Clinical Trial Supplies Market - Emerging Trends & Global Future Forecasts

Major Growth Boosting Factors:

The increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations are the key factors driving the growth of this market.

Expected Revenue Surge:

The clinical trial supplies market is projected to reach USD 2.5 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 7.8%. 

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

Report Objectives:

# To define, describe, and forecast the market on the basis of service, phase, drug type, therapeutic area, and region.

# To provide detailed information regarding the major factors influencing the growth of the market.

# To strategically analyze micromarkets with respect to their individual growth trends, future prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the size of the market segments with respect to four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World.

# To profile key market players and comprehensively analyze their product portfolios, market positions, and core competencies.

# To track and analyze competitive developments such as acquisitions, new product launches, expansions, agreements, partnerships, collaborations, and R&D activities in the clinical trial supplies market.

Geographical Growth Expectations:

North America is the largest regional market for clinical trial supplies

Currently, North America is the largest regional market for clinical trial supplies, and this trend is expected to continue during the forecast period of 2020 to 2025. The presence of well-established CROs and the high and growing investments in R&D by pharmaceutical and biopharmaceutical companies are the major factors responsible for the large share of North America in the global clinical trial supplies market. However, owing to the presence of a larger patient population and less-stringent patient recruitment regulations, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=172240059

Key Players:

The clinical trial supplies market is consolidated in nature. The prominent players operating in this market include Alamc Group (UK), Catalent, Inc. (US), PCI Services (US), Parexel International Corporation (US), Sharp Packaging Services (US), Biocair (UK), O&M Movianto (US), KLIFO A/S (Denmark), and Thermo Fisher Scientific, Inc. (US).

Catalent, Inc. (US) is the leading player in the global clinical trial supplies market. The company has an extensive network that provides comprehensive services to various pharmaceutical companies for phase I–IV clinical trials. Catalent’s offerings in the clinical trial supplies market include forecasting and planning services, packaging services, comparator sourcing, and distribution and logistics services. In 2018, Catalent generated ~51% of its total revenue from the US. Also, the company is focusing on increasing its customer base and expanding its reach in untapped APAC markets.

Almac Group (UK) is another major player in the global clinical trial supplies market. The company offers a wide range of services, from research through pharmaceutical and clinical development to the commercialization of products.

Read the Detailed Article@ 

https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html

Using Gumroad e-Commerce Platform, You can Sell Your Product Directly to the Consumer

Summary:

Gumroad e-Commerce Platforms is an online aggregator platform that allows users to sell products ranging from books to softwares and tutorials to films to customers directly without the hassles of a marketplace model. It allows users to start selling just by signing up and clicking on the sell button without having to spend too much time on the business aspect of things.

GUMROAD USP:

Gumroad e-commerce Platforms helps creators of all types from artists to designers and filmmakers to software developers sell their products directly to customers without having to be bogged down by the hassles of running a business. Gumroad e-commerce Platforms offers payment processing, marketing and communication tools, analytics and improved consumption experiences. It emphasises largely on the creator consumer journey.

Read More on Best E-Commerce Platforms@

https://www.360quadrants.com/press-release/360quadrants-releases-quadrant-on-best-e-commerce-platforms

Gumroad Pricing:

There are two plans of Gumroad pricing. One is free, a default account created on signing up. Gumroad pricing for a premium account that starts at $10/month, which is essentially 3.5% + $0.30 per sale. While the free account allows creating and customising storefront, selling as many products, sending out four updates a month and setting up one automated email workflow. The premium account allows unlimited posts and workflows, third-party analysis, custom delivery products, the ability to use custom domains and importing customers.

Gumroad Demo:

Gumroad e-commerce Platforms offers free demo upon requesting information after logging on to the website and by sharing an email address with the company.

Read More About, 8 Best e-commerce platforms in 2020@

https://blog.360quadrants.com/2020/top-vendors-providing-e-commerce-platform/

Features:

Personalised landing page:

# Have a personalised home page to connect with the audience

# Embed Gumroad’s follow form on existing blog or website to direct traffic on page

Assistance in building audience

# Gain access to user data to increase audience engagement and improve ROI

# Import and export contact data at any point in time

Assistance in selling digital products

# Promote your product by highlighting image, audio or video covers and explore marketing techniques

# Focus on product design for selling software products while Gumroad handles license keys

Easy selling of physical products

# Mark packages as shipped and send tracking numbers to customers to enable tracking

# Set shipping rates, charge buyers on the basis of their location and restrict product sales by country and create offer codes to reward fans or go on a one-day sale

Read the Detailed Report@

https://www.360quadrants.com/software/e-commerce-platforms